Harvard Bioscience (HBIO) Tops Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $6.23 -0.8%
Financial Fact:
Cost of product revenues: 13.32M
Today's EPS Names:
CCEL, SLP, TMQ, More
Financial Fact:
Cost of product revenues: 13.32M
Today's EPS Names:
CCEL, SLP, TMQ, More
Join SI Premium – FREE
Harvard Bioscience (NASDAQ: HBIO) reported Q1 EPS of $0.06, $0.02 better than the analyst estimate of $0.04. Revenue for the quarter came in at $30 million versus the consensus estimate of $28.95 million.
For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Key things to know ahead of SK Hynix’s blockbuster US listing
- Carmila agrees to buy Dijon shopping centre for €45 million
- JPMorgan Downgrades PhysicsWallah Ltd (PWL:IN) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
